Reply to Scagnolari et al

J Infect Dis. 2017 Feb 1;215(3):493-494. doi: 10.1093/infdis/jiw580.

Authors

Ashley N Brown¹, Karen M Gallegos¹, David Z D'Argenio², George L Drusano¹

Affiliations

¹ Institute for Therapeutic Innovation, Department of Medicine, University of Florida, Orlando.
² Department of Biomedical Engineering, University of Southern California, Los Angeles.

PMID: 28003357
DOI: 10.1093/infdis/jiw580

No abstract available

Publication types

Comment

MeSH terms

Antiviral Agents*
Chikungunya virus*
Interferons
Ribavirin

Substances

Antiviral Agents
Ribavirin
Interferons